Onderneming Recipharm publ AB Swiss Exchange
Aandelen
SE0005757267
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- SEK | - |
2023 | Synokem Pharmaceuticals Limited verwierf 74% belang in Nitin Lifesciences Limited van Recipharm AB (publ). | CI |
2023 | Recipharm kondigt wijzigingen aan in CEO | CI |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Grégory Behar
CEO | Chief Executive Officer | 55 | 01/01 |
Director of Finance/CFO | - | 03-04-23 | |
Ulrike Lemke
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-21 |
Luc Burgard
COO | Chief Operating Officer | 43 | - |
Marc Funk
BRD | Director/Board Member | 64 | 01-01-21 |
Human Resources Officer | - | - | |
Kieran Chouhan
PRN | Corporate Officer/Principal | - | 01-02-19 |
Bernard Pluta
PRN | Corporate Officer/Principal | - | 01-10-15 |
Shabbir Mostafa
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 60 | 01-06-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Klosk
BRD | Director/Board Member | 67 | 01-03-21 |
Director/Board Member | 67 | 01-01-21 | |
Richard Ridinger
CHM | Chairman | 66 | 01-03-21 |
Marc Funk
BRD | Director/Board Member | 64 | 01-01-21 |
Director/Board Member | 43 | 01-03-21 | |
Henrik Giver
BRD | Director/Board Member | 35 | 01-01-21 |
Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 370 000 | 0 | 0 | 56,25 % |
Aandeel B | 10 | 21 312 000 | 0 | 0 | |
Aandeel C | 1 | 79 803 683 | 57 089 305 ( 71,54 %) | 0 |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Recipharm Ltd.
Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom. |
Pharmaceuticals: Major
|
Recipharm Venture Fund AB
Recipharm Venture Fund AB Investment ManagersFinance Recipharm Venture Fund AB is a venture capital fund that makes strategic investments in start-ups and biotechnology companies that are seen as important to Recipharm's business. The fund invests in both private and public companies. |
Investment Managers
|
Recipharm Holdings Ltd.
Recipharm Holdings Ltd. MiscellaneousMiscellaneous Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom. |
Miscellaneous
|
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,85% | 72,5 mld. | |
+13,31% | 9,11 mld. | |
-12,85% | 5,07 mld. | |
+60,16% | 5,01 mld. | |
+1,60% | 3,85 mld. | |
-19,20% | 2,46 mld. | |
+18,65% | 2,44 mld. | |
+24,62% | 2,27 mld. | |
-27,46% | 2,26 mld. |
- Beurs
- Aandelen
- Koers RECI B
- Koers
- Onderneming Recipharm publ AB